The biggest catalyst for Reinsurance RZC nobody is watching At Lows 20260505 KLA Corporation KLAC Valuation Assessment Following 161 12Month Share Price Surge The debt management strategy at Boyd Group BGSI Q4 2025 Earnings Beat Estimates TPST Tempest Therapeutics climbs 251 percent following narrow Q4 2025 EPS beat that lifts investor sentiment